This article is more than 5 years old. Information may no longer be current.

Korean court system finds kyphoplasty device infringes a Medtronic patent

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Medtronic, Inc. announced in a press release that the High Court in Seoul, Korea has found that the balloon kyphoplasty device made by Taeyeon Medical Co., Ltd. infringes a valid Medtronic patent and has ordered destruction of Taeyeon’s stock of the infringing device and related manufacturing equipment.

“We are pleased by the High Court’s ruling,” Alex DiNello, vice president and general manager of the Kyphon Products Division of Medtronic, stated in the release. “We have solid patents protecting our kyphoplasty products, and we are committed to vigorously defending our intellectual property.”

Taeyeon brands impacted by this legal decision are Typhoon and Balex. The product and manufacturing equipment destruction order was enforced on October 12, 2010 by bailiffs of the Korean court. Taeyeon is appealing the decision to the Korean Supreme Court.